Introduction
The pharmaceutical industry has a growing need for efficient analytical laboratories that can keep up with the increasing workload generated by other areas within the industry. The increased sample throughput and quick turnover of analytical data are key factors for speedy new product approval by regulatory agencies. To keep up with the continuous increase in workload generated for these laboratories, full automation is determined to be an unavoidable task. This applies to instrumentation, computers and data management, as well as to sample preparation. Efficiency in chemical laboratories is greatly improved by applying automated sample preparation technology. Automated sample preparation via robotics also improves safety and minimizes exposure ofpersonnel to hazardous materials, which helps to achieve Good Laboratory Practice (GLP).
The process of acquiring a laboratory robot may differ from one organization to another. The first-time acquisition of a laboratory robot is the most critical, where the outcome of the event will greatly affect future decisions. Based on experience within New Brunswick facility, the different stages of the decision-making process and the start-up procedure of a laboratory robotic system are discussed. Typical examples of various applications within the pharmaceutical industry are presented.
The process of acquiring robotic system
The following is a list of the important issues to be addressed during this process:
(1) Initial study.
(2) Justification. Figure 5 shows the use of the robot to analyse pharmaceutical products and metabolites in biological fluids. In vivo bioavailability is an important parameter during the product development stage.
The system shown in figure 6 is designed to serve the radiopharmaceutical area. The parts of the robot that handle radioactive material are clad with lead sheets. The 
